US Merck Prevails In Vaccine IP Battle Against Pfizer
A London judge hit Pfizer Inc. with a one-two punch on Thursday, invalidating a patent for its top-selling Prevnar 13 pneumonia vaccine and also saying the pharmaceutical giant's infringement claims against...To view the full article, register now.
Already a subscriber? Click here to view full article